108 related articles for article (PubMed ID: 349438)
1. Oral contraceptive potencies and side effects.
Berger GS; Talwar PP
Obstet Gynecol; 1978 May; 51(5):545-7. PubMed ID: 349438
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
Ayangade O; Akinyemi A
Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
[TBL] [Abstract][Full Text] [Related]
3. A randomized double blind study of two oral contraceptives.
Sanhueza H; Sivin I; Kumar S; Kessler M; Carrasco A; Yee J
Contraception; 1979 Jul; 20(1):29-48. PubMed ID: 477315
[TBL] [Abstract][Full Text] [Related]
4. Comparative trials of low-dose combined oral contraceptives.
Edelman DA; Kothenbeutel R; Levinski MJ; Kelly SE
J Reprod Med; 1983 Mar; 28(3):195-200. PubMed ID: 6854550
[TBL] [Abstract][Full Text] [Related]
5. The probability of side effects with ovral, norinyl 1/50 and norlestrin.
Berger GS; Edelman DA; Talwar PP
Contraception; 1979 Nov; 20(5):447-53. PubMed ID: 160860
[TBL] [Abstract][Full Text] [Related]
6. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
7. An assessment of the side effects of switching from one oral contraceptive to another.
Edelman DA; Kothenbeutel R; Levinski MJ; Talwar PP
Int J Gynaecol Obstet; 1976; 14(5):397-400. PubMed ID: 15904
[TBL] [Abstract][Full Text] [Related]
8. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
9. A comparison of Norinyl and Brevicon in three sites in Sri Lanka.
Basnayake S; de Silva SV; Miller PC; Rogers S
Contraception; 1983 May; 27(5):453-64. PubMed ID: 6884024
[TBL] [Abstract][Full Text] [Related]
10. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
11. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
Damber MG; von Schoultz B; Solheim F; Stigbrand T
Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
[TBL] [Abstract][Full Text] [Related]
12. Sri Lanka pill and vitamin trial produces important data.
Netw Res Triangle Park N C; 1981 Oct; 3(1):1-2. PubMed ID: 12263432
[TBL] [Abstract][Full Text] [Related]
13. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. I. Blood and urinary lactate, uric acid, and phosphorus.
Kelsay JL; Behall KM; Moser PB; Prather ES
Am J Clin Nutr; 1977 Dec; 30(12):2016-22. PubMed ID: 930871
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral contraceptives on nutrients. III. Vitamins B6, B12, and folic acid.
Prasad AS; Lei KY; Moghissi KS; Stryker JC; Oberleas D
Am J Obstet Gynecol; 1976 Aug; 125(8):1063-9. PubMed ID: 952302
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral contraceptive agents on nutrients: II. Vitamins.
Prasad AS; Oberleas D; Moghissi KS; Stryker JC; Lei KY
Am J Clin Nutr; 1975 Apr; 28(4):385-91. PubMed ID: 1168019
[TBL] [Abstract][Full Text] [Related]
17. Effects of contraceptive pills and intrauterine devices on urinary bladder.
Zahran MM; Osman MI; Kamel M; Fayad M; Mooro H; Youssef AF
Urology; 1976 Dec; 8(6):567-74. PubMed ID: 793141
[TBL] [Abstract][Full Text] [Related]
18. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T
Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
20. The effect of contraceptive steroids on hypothalamic-pituitary function.
Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
